Nigerian Association of Resident Doctors Suspends Nationwide Strike

The Nigerian Association of Resident Doctors (NARD) has taken the decision to halt its nationwide strike, bringing relief to the healthcare sector and patients across the country.

Advertisement

The strike, which was initiated as a means to assert their demands from the federal government, has been temporarily suspended.

Demands and Objectives

One of the key motivations behind the strike was the pressing demand for the payment of the 2023 medical residency training fund (MRTF).

NARD members were resolute in their call for the immediate release of the circular pertaining to the one-for-one replacement policy.

Alongside this, they advocated for an upward revision of the consolidated medical salary structure (CONMESS), underscoring the financial aspect of their demands.

Advertisement

Furthermore, the resident doctors highlighted the need for the clearance of outstanding arrears encompassing consequential adjustment, hazard allowance, and skipping allowance.

These issues collectively formed the core of their concerns, reflecting both financial and workplace-related grievances.

Resolution and Future Prospects

In a significant turn of events, President of NARD, Emeka Orji, conveyed that the decision to suspend the strike was reached on a Friday evening.

He conveyed that the resident doctors are prepared to resume their duties promptly at 8 am the following day.

However, Orji emphasized that this suspension is provisional and that they intend to assess the progress achieved within a span of two weeks.

Advertisement

The termination of the strike is anticipated to provide a temporary reprieve to the healthcare system and the patients who have been affected.

As the details unfold, the broader implications of this decision and the subsequent negotiations between NARD and the government will likely come to light, potentially shaping the future landscape of the medical profession in Nigeria.

Advertisement

Read More On The Topic On TDPel Media

Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn